XML 17 R5.htm IDEA: XBRL DOCUMENT v3.5.0.2
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2016
Sep. 30, 2015
Cash Flows from Operating Activities:    
Net income (loss) $ 28,659 $ (15,384)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 14,662 15,798
Provision for doubtful accounts 13,664 9,370
Non-cash compensation 12,556 7,637
401(k) employer match 5,134 4,544
Loss on disposal of property and equipment 556 945
Gain on sale of care centers 0 (184)
Deferred income taxes 18,689 (9,547)
Write off deferred debt issuance costs 0 2,513
Equity in earnings from equity method investments (3,602) (8,701)
Amortization of deferred debt issuance costs/debt discount 555 774
Return on equity investment 1,913 5,135
Asset impairment charge 0 77,268
Changes in operating assets and liabilities, net of impact of acquisitions:    
Patient accounts receivable (46,107) (31,788)
Other current assets 870 12,701
Other assets (11,909) (803)
Accounts payable 7,308 8,597
Accrued expenses (9,100) 9,152
Other long-term obligations (150) (286)
Net cash provided by operating activities 33,698 87,741
Cash Flows from Investing Activities:    
Proceeds from sale of deferred compensation plan assets 230 1,077
Purchases of deferred compensation plan assets 0 (19)
Purchases of property and equipment (13,502) (17,969)
Purchase of investment (750) (2,561)
Proceeds from sale of investment 0 5,000
Acquisitions of businesses, net of cash acquired (31,378) (5,800)
Proceeds from dispositions of care centers 0 413
Net cash used in investing activities (45,400) (19,859)
Cash Flows from Financing Activities:    
Proceeds from issuance of stock upon exercise of stock options and warrants 0 399
Proceeds from issuance of stock to employee stock purchase plan 1,818 1,591
Tax benefit from stock options exercised and restricted stock vesting 7,241 0
Non-controlling interest distribution (284) (300)
Sale of non-controlling interest 405 0
Proceeds from revolving line of credit 128,500 63,400
Repayments of revolving line of credit (128,500) (78,400)
Proceeds from issuance of long-term obligations 0 100,000
Principal payments of long-term obligations (3,750) (103,000)
Debt issuance costs 0 (2,553)
Purchase of company stock (12,315) 0
Net cash used in financing activities (6,885) (18,863)
Net (decrease) increase in cash and cash equivalents (18,587) 49,019
Cash and cash equivalents at beginning of period 27,502 8,032
Cash and cash equivalents at end of period 8,915 57,051
Supplemental Disclosures of Cash Flow Information:    
Cash paid for interest 2,276 5,598
Cash paid for income taxes, net of refunds received $ 758 $ (12,383)